Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
NKGN holding history
NKGen Biotech, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKGN overviewAll 13F holders of NKGNFull Q4 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −227,804−100.0% | Sold out | Holders |
| Q4 2024 | 227,804 | $149.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 227,804 | $86.1K | <0.1% | +174,000+323.4% | Added | Holders |
| Q2 2024 | 53,804 | $68.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 53,804 | $101.7K | <0.1% | +53,804 | New | Holders |